BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16103107)

  • 1. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
    Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
    BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
    Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
    PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility.
    Johnson N; Fletcher O; Palles C; Rudd M; Webb E; Sellick G; dos Santos Silva I; McCormack V; Gibson L; Fraser A; Leonard A; Gilham C; Tavtigian SV; Ashworth A; Houlston R; Peto J
    Hum Mol Genet; 2007 May; 16(9):1051-7. PubMed ID: 17341484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of variation in miRNA-binding site (rs8176318) of the BRCA1 gene in breast cancer patients.
    Ahmad M; Jalil F; Haq M; Shah Ali
    Turk J Med Sci; 2019 Oct; 49(5):1433-1438. PubMed ID: 31651107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.
    Pajares B; Porta J; Porta JM; Sousa CF; Moreno I; Porta D; Durán G; Vega T; Ortiz I; Muriel C; Alba E; Márquez A
    BMC Cancer; 2018 Jun; 18(1):647. PubMed ID: 29884136
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Akilzhanova AR; Nyshanbekkyzy B; Nurkina ZM; Shtephanov II; Makishev AK; Adylkhanov TA; Rakhypbekov TK; Ramanculov EM; Momynaliev KT
    Cent Asian J Glob Health; 2013; 2(1):29. PubMed ID: 29755871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
    Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of
    Buleje J; Guevara-Fujita M; Acosta O; Huaman FDP; Danos P; Murillo A; Pinto JA; Araujo JM; Aguilar A; Ponce J; Vigil C; Castaneda C; Calderon G; Gomez HL; Fujita R
    Mol Genet Genomic Med; 2017 Sep; 5(5):481-494. PubMed ID: 28944232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-4717 differentially interacts with its polymorphic target in the PD1 3' untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases.
    Zhang G; Li N; Li Z; Zhu Q; Li F; Yang C; Han Q; Lv Y; Zhou Z; Liu Z
    Oncotarget; 2015 Aug; 6(22):18933-44. PubMed ID: 25895129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?
    Paltsev M; Kiselev V; Muyzhnek E; Drukh V; Kuznetsov I; Pchelintseva O
    EPMA J; 2013 Dec; 4(1):25. PubMed ID: 24325835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation of the brca1 and brca2 genes in macedonian patients.
    Maleva I; Madjunkova S; Bozhinovski G; Smickova E; Kondov G; Spiroski Z; Arsovski A; Plaseska-Karanfilska D
    Balkan J Med Genet; 2012 Dec; 15(Suppl):81-5. PubMed ID: 24052750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.
    Ricks-Santi LJ; Nie J; Marian C; Ochs-Balcom HM; Trevisan M; Edge SB; Kanaan Y; Freudenheim JL; Shields PG
    Genet Epidemiol; 2013 Jul; 37(5):504-11. PubMed ID: 23674270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of the human reference genome for personalized genomics.
    Rosenfeld JA; Mason CE; Smith TM
    PLoS One; 2012; 7(7):e40294. PubMed ID: 22811759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon.
    Jalkh N; Nassar-Slaba J; Chouery E; Salem N; Uhrchammer N; Golmard L; Stoppa-Lyonnet D; Bignon YJ; Mégarbané A
    Hered Cancer Clin Pract; 2012 Jun; 10(1):7. PubMed ID: 22713736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
    Cox DG; Simard J; Sinnett D; Hamdi Y; Soucy P; Ouimet M; Barjhoux L; Verny-Pierre C; McGuffog L; Healey S; Szabo C; Greene MH; Mai PL; Andrulis IL; ; Thomassen M; Gerdes AM; Caligo MA; Friedman E; Laitman Y; Kaufman B; Paluch SS; Borg Å; Karlsson P; Askmalm MS; Bustinza GB; ; Nathanson KL; Domchek SM; Rebbeck TR; Benítez J; Hamann U; Rookus MA; van den Ouweland AM; Ausems MG; Aalfs CM; van Asperen CJ; Devilee P; Gille HJ; ; ; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Paterson J; Eason J; Godwin AK; Remon MA; Moncoutier V; Gauthier-Villars M; Lasset C; Giraud S; Hardouin A; Berthet P; Sobol H; Eisinger F; Bressac de Paillerets B; Caron O; Delnatte C; ; Goldgar D; Miron A; Ozcelik H; Buys S; Southey MC; Terry MB; ; Singer CF; Dressler AC; Tea MK; Hansen TV; Johannsson O; Piedmonte M; Rodriguez GC; Basil JB; Blank S; Toland AE; Montagna M; Isaacs C; Blanco I; Gayther SA; Moysich KB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Sutter C; Gadzicki D; Fiebig B; Caldes T; Laframboise R; Nevanlinna H; Chen X; Beesley J; Spurdle AB; Neuhausen SL; Ding YC; Couch FJ; Wang X; Peterlongo P; Manoukian S; Bernard L; Radice P; Easton DF; Chenevix-Trench G; Antoniou AC; Stoppa-Lyonnet D; Mazoyer S; Sinilnikova OM;
    Hum Mol Genet; 2011 Dec; 20(23):4732-47. PubMed ID: 21890493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
    Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG
    BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.
    Pelletier C; Speed WC; Paranjape T; Keane K; Blitzblau R; Hollestelle A; Safavi K; van den Ouweland A; Zelterman D; Slack FJ; Kidd KK; Weidhaas JB
    Cell Cycle; 2011 Jan; 10(1):90-9. PubMed ID: 21191178
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.